Constitution d'Une Cohorte Prospective de Sujets Sains et Malades et d'Une Collection de Ressources Biologiques associées Pour l'étude du système Immunitaire et de Ses déterminants Génétiques et Environnementaux"
The CoSImmGEn study, sponsored by Institut Pasteur, aims to establish a comprehensive cohort of healthy and sick subjects to investigate the immune system's genetic and environmental influences. This initiative addresses a significant gap in population cohorts, providing valuable biological resources for both public and private research entities globally. The potential applications of the findings could extend to various therapeutic areas, including autoimmune diseases, infectious diseases, and cancer, positioning the study as a critical asset for future collaborations and partnerships in the biopharmaceutical industry. The open-access nature of the biological resources may enhance the study's attractiveness to external researchers and companies, fostering innovation and development in immunology.
Indication: Immune System and Related Disorders
Modality: gene therapy
Target: Immune system and its genetic and environmental determinants
Sponsor: Institut Pasteur
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 03, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Immune system and its genetic and environmental determinants
View original source fields
Condition raw: Immune System and Related Disorders
Condition normalized: Immune System and Related Disorders
Modality raw: gene therapy
Modality normalized: gene therapy
Target raw: Immune system and its genetic and environmental determinants
Target normalized: Immune system and its genetic and environmental determinants